Stäubli Robotics and Quantum Surgical, both European leaders in their respective fields, are joining forces to create a Centre of excellence in oncology robotics.
Family-owned Stäubli Robotics, a division of the Stäubli Group, is a leading international player in industrial automation. Stäubli Robotics designs, manufactures, and markets a complete range of robots adapted to all needs, even the most specific, such as in the field of medicine.
Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer.
This strategic partnership aims to combine this savoir-faire to strengthen the role of robotics in minimally invasive cancer treatments and to build a world leader.
A memorandum of understanding has been signed by the two parties.
“We are extremely grateful and proud that Quantum Surgical confirms their trust in Stäubli as a partner of choice for this new patient care application, at the service of human well-being. We are excited to contributing to Quantum’s vision together, with a long-term partner that stimulates us on a daily basis and makes us better.” announces Gerald Vogt, Group Division Stäubli Robotics.
“We are honored to work with Stäubli, a company recognized for its technological excellence and savoir-faire, in order to share a vision of robotics and automation in healthcare” , explains Bertin Nahum, President, and Founder of Quantum Surgical.
Co-founded in 2017 by Bertin Nahum, Quantum Surgical is an innovative surgical robotic company based in Montpellier (France). Quantum Surgical’s robotic solution is a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer. This platform combining robotics, image analytics, and artificial intelligence will allow more and more patients to benefit from safer interventional oncology procedures, especially in the case of early-stage liver cancers. The incidence of liver cancer in the population is, unfortunately, growing very rapidly. Liver cancer is one of the most common cancers with more than 800,000 cases each year in the world. Quantum Surgical is backed by leading global life science investment fund Ally Bridge Group since inception.
Further information is available here: quantumsurgical.com.